SCHEMBL2796904

SCHEMBL2796904

COc1ccc(NC(=O)OC(C)(C)C)c(OCCCBr)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 1/20 0.44
LPAR1 Q92633 1/20 0.43
MAPT P10636 3/20 0.43
CYP1A2 P05177 2/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42
MAPK1 P28482 1/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
ABCB1 P08183 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31372094 1.00 ALDH1A1 (0.48) ALDH1A1HPGDNPC1RAB9AMEN1
SCHEMBL13282637 0.90 ALDH1A1 (0.50) ALDH1A1HPGDNPC1RAB9AMEN1
SCHEMBL23177747 0.86 SMN1; SMN2 (0.43) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL29429219 0.86 SMN1; SMN2 (0.43) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL2795656 0.84 ALDH1A1 (0.54) ALDH1A1HPGDNPC1RAB9AMEN1
SCHEMBL2589170 0.83 ALDH1A1 (0.63) ALDH1A1HPGDNPC1RAB9AMEN1
SCHEMBL24253966 0.78 POLB (0.56) ALDH1A1RAB9AMEN1POLBKMT2A
SCHEMBL22077183 0.77 MAPT (0.55) ALDH1A1HPGDNPC1RAB9AKMT2A
SCHEMBL24254051 0.76 ALDH1A1 (0.46) ALDH1A1MEN1KMT2ALPAR1MAPT
SCHEMBL1422634 0.76 FAAH (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010077915-A1 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-07-08 WO disclosed
US-20100168080-A1 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS KHAMRAI UTTAM 2010-07-01 US disclosed
US-20100168080-A1 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS KHAMRAI UTTAM 2010-07-01 US disclosed
US-20100168080-A1 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS KHAMRAI UTTAM 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168080-A1 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS CCR1, CCR5, CCR3 ALDH1A1 1547/4885HPGD 1778/4885NPC1 510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.